Katelyn W Sylvester

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 7

Top Topics

Venous Thromboembolism

Atrial Fibrillation

Direct Oral Anticoagulants

Top Venues

Research and practice in thrombosis and haemostasis

Journal of thrombosis and thrombolysis

American journal of hematology

Journal of thrombosis and haemostasis : JTH

This page only lists publications with an associated author ORCID identifier.

Publications

Katelyn W Sylvester, Alisia Chen, Andrea R Lewin, John Fanikos, Samuel Z Goldhaber, Jean Marie Connors
Optimization of DOAC management services in a centralized anticoagulation clinic. Research and practice in thrombosis and haemostasis 6 (3) (2022)
Lachelle Dawn Weeks, Katelyn W Sylvester, Jean Marie Connors, Nathan T Connell
Management of therapeutic unfractionated heparin in COVID-19 patients: A retrospective cohort study. Research and practice in thrombosis and haemostasis 5 (4) (2021)
Julie Kelly, Katelyn W Sylvester, Jessica Rimsans, Thomas D Bernier, Clara Ting, Jean Marie Connors
Heparin-induced thrombocytopenia in end-stage renal disease: Reliability of the PF4-heparin ELISA. Research and practice in thrombosis and haemostasis 5 (5) (2021)
Charlie J Nederpelt, Leon Naar, Katelyn W Sylvester, Megan E Barra, Russel J Roberts, George C Velmahos, Haytham M A Kaafarani, Martin G Rosenthal, David R King
Evaluation of oral factor Xa inhibitor-associated extracranial bleeding reversal with andexanet alfa. Journal of thrombosis and haemostasis : JTH 18 (10) (2020)
Sarah E Culbreth, Katelyn W Sylvester, Jessica Rimsans, Jean Marie Connors
Coordinating emergent procedures after andexanet alfa. American journal of hematology 94 (10) (2019)
Katelyn W Sylvester, Clara Ting, Andrea Lewin, Peter Collins, John Fanikos, Samuel Z Goldhaber, Jean M Connors
Expanding anticoagulation management services to include direct oral anticoagulants. Journal of thrombosis and thrombolysis 45 (2) (2018)
Katelyn W Sylvester, Jean Marie Connors
Overcoming barriers to integrating direct oral anticoagulants into existing anticoagulation management services. Research and practice in thrombosis and haemostasis 3 (1) (2018)